C. Ellen van der Schoot

24.6k citations

332 papers · 11.5k indexed · 1 hit paper · h-index 57

Hematology top 0.05%
Molecular Biology top 2%
Immunology top 1%
Pediatrics, Perinatology and Child Health top 0.2%
Genetics top 0.2%

Co-authors: Masja de Haas A. E. G. Kr. von dem Borne Carlijn Voermans Gestur Vidarsson Joke M. Koelewijn Jacques J. M. van Dongen Petra A. Maaskant‐van Wijk Marion Kleijer
Topics: Blood groups and transfusion (141 papers)Platelet Disorders and Treatments (67 papers)Erythrocyte Function and Pathophysiology (53 papers)
Cited by: Hematology Genetics Immunology and Allergy
Journals: Nature Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: Netherlands United Kingdom Germany

In The Last Decade

C. Ellen van der Schoot

323 papers receiving 11.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program

2003 656 citations C. Ellen van der Schoot et al. profile →

Peers

Countries citing papers authored by C. Ellen van der Schoot

Since Specialization

Citations

This map shows the geographic impact of C. Ellen van der Schoot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Ellen van der Schoot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Ellen van der Schoot more than expected).

Fields of papers citing papers by C. Ellen van der Schoot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Ellen van der Schoot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Ellen van der Schoot. The network helps show where C. Ellen van der Schoot may publish in the future.

Co-authorship network of co-authors of C. Ellen van der Schoot

This figure shows the co-authorship network connecting the top 25 collaborators of C. Ellen van der Schoot. A scholar is included among the top collaborators of C. Ellen van der Schoot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Ellen van der Schoot. C. Ellen van der Schoot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fucosylation limits ADCC in clinically used anti‐RhD monoclonal antibodies 2025 ·Transfusion ·(unknown),Albert Bondt,(unknown),(unknown),(unknown),Peter C. Ligthart,E. J. T. Verweij,Albert J. R. Heck,C. Ellen van der Schoot,Gestur Vidarsson	0
2	HPA-1a antibodies in FNAIT do not distinguish αvβ3 from αIIbβ3, and bind inactive integrins more strongly than active integrins 2025 ·Blood ·(unknown),(unknown),(unknown),Arthur E. H. Bentlage,(unknown),José M. de Pereda,Leendert Porcelijn,Rick Kapur,Masja de Haas,C. Ellen van der Schoot,Gestur Vidarsson,Coert Margadant	0
3	Real‐world performance of a clinical droplet digital polymerase chain reaction assay for non‐invasive foetal blood group and platelet antigen genotyping of alloimmunized pregnant women with antibodies directed against RhD, RhE, Rhc, RhC, K1, HPA‐1a or HPA‐5b: A 1‐year experience 2024 ·Vox Sanguinis ·(unknown),O. J. H. M. Verhagen,(unknown),Christa Homburg,(unknown),(unknown),(unknown),C. Ellen van der Schoot,Masja de Haas	2
4	Cell-Free RNA from Plasma in Patients with Neuroblastoma: Exploring the Technical and Clinical Potential 2023 ·Cancers ·(unknown),(unknown),Lieke M. J. van Zogchel,(unknown),(unknown),Lily Zappeij‐Kannegieter,Laura Bongiovanni,(unknown),Janine Stutterheim,C. Ellen van der Schoot,Alain de Bruin,Godelieve A.M. Tytgat	5
5	Improving Risk Stratification for Pediatric Patients with Rhabdomyosarcoma by Molecular Detection of Disseminated Disease 2021 ·Clinical Cancer Research ·(unknown),(unknown),Lily Zappeij‐Kannegieter,Lieke M. J. van Zogchel,Marta Fiocco,Max M. van Noesel,Johannes H. M. Merks,C. Ellen van der Schoot,Godelieve A.M. Tytgat,Janine Stutterheim	11
6	Afucosylated Plasmodium falciparum-specific IgG is induced by infection but not by subunit vaccination 2021 ·Nature Communications ·Mads Delbo Larsen,Mary Lopez-Perez,(unknown),(unknown),Nicaise Tuikue Ndam,Jan Nouta,Carolien A. M. Koeleman,Agnes L. Hipgrave Ederveen,Benjamin Mordmüller,Ali Salanti,Morten A. Nielsen,Achille Massougbodji,C. Ellen van der Schoot,Michael F. Ofori,Manfred Wuhrer,Lars Hviid,Gestur Vidarsson	39
7	SMIM1 missense mutations exert their effect on wild type Vel expression late in erythroid differentiation 2020 ·Transfusion ·(unknown),(unknown),Francesca Aglialoro,C. Ellen van der Schoot,Emile van den Akker	2
8	Biological and structural characterization of murine TRALI antibody reveals increased Fc-mediated complement activation 2020 ·Blood Advances ·(unknown),Saskia van der Velden,Arthur E. H. Bentlage,Mads Delbo Larsen,(unknown),Juk Yee Mok,Giso Brasser,(unknown),Carolien A. M. Koeleman,Jan Nouta,John W. Semple,Leendert Porcelijn,Wim J.E. van Esch,Manfred Wuhrer,C. Ellen van der Schoot,Gestur Vidarsson,Rick Kapur	11
9	Anti‐platelet antibodies in childhood immune thrombocytopenia: Prevalence and prognostic implications 2020 ·Journal of Thrombosis and Haemostasis ·David E. Schmidt,Katja M. J. Heitink‐Pollé,Leendert Porcelijn,C. Ellen van der Schoot,Gestur Vidarsson,Marrie C.A. Bruin,Masja de Haas	14
10	Identification of genetic biomarkers for alloimmunization in sickle cell disease 2019 ·British Journal of Haematology ·Sanne M. Meinderts,(unknown),(unknown),Martin de Boer,Karin van Leeuwen,Bart J. Biemond,Anita W. Rijneveld,Jean‐Louis Kerkhoffs,Anoosha Habibi,Robin van Bruggen,Taco W. Kuijpers,C. Ellen van der Schoot,France Pirenne,Karin Fijnvandraat,Michael W.T. Tanck,Timo K. van den Berg	16
11	Identification of a novel single‐nucleotide mutation in SMIM1 gene that results in low Vel antigen expression 2019 ·Transfusion ·(unknown),(unknown),Barbera Veldhuisen,(unknown),Emile van den Akker,C. Ellen van der Schoot	2
12	Reduced FcRn-mediated transcytosis of IgG2 due to a missing Glycine in its lower hinge 2019 ·Scientific Reports ·Nigel M. Stapleton,Maximilian Brinkhaus,Kathryn L. Armour,Arthur E. H. Bentlage,Steven W. de Taeye,(unknown),Juk Yee Mok,Giso Brasser,(unknown),Wim J.E. van Esch,Mike Clark,Lorna M. Williamson,C. Ellen van der Schoot,Gestur Vidarsson	26
13	Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms 2019 ·Blood Advances ·David E. Schmidt,Katja M. J. Heitink‐Pollé,(unknown),Marrie C.A. Bruin,Barbera Veldhuisen,Sietse Q. Nagelkerke,Taco W. Kuijpers,Leendert Porcelijn,C. Ellen van der Schoot,Gestur Vidarsson,Masja de Haas	16
14	Adaptive antibody diversification through N -linked glycosylation of the immunoglobulin variable region 2018 ·Proceedings of the National Academy of Sciences ·Fleur S. van de Bovenkamp,Ninotska I. L. Derksen,Pleuni Ooijevaar‐de Heer,Karin A. van Schie,Simone Kruithof,Magdalena A. Berkowska,C. Ellen van der Schoot,Hanna IJspeert,Mirjam van der Burg,Ann Gils,Lise Hafkenscheid,René E. M. Toes,Yoann Rombouts,Rosina Plomp,Manfred Wuhrer,S. Marieke van Ham,Gestur Vidarsson,Theo Rispens	99
15	Peripheral Stem Cell Apheresis is Feasible Post 131Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet Reconstitution 2018 ·Clinical Cancer Research ·Kathelijne C.J.M. Kraal,Ilse Timmerman,(unknown),Cor van den Bos,József Zsíros,Henk van den Berg,(unknown),Eric Braakman,(unknown),Max M. van Noesel,C. Ellen van der Schoot,Marta Fiocco,Huib N. Caron,Carlijn Voermans,Godelieve A.M. Tytgat	5
16	Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation 2017 ·Scientific Reports ·Myrthe E. Sonneveld,Masja de Haas,Carolien A. M. Koeleman,Noortje de Haan,Sacha Zeerleder,Peter C. Ligthart,Manfred Wuhrer,C. Ellen van der Schoot,Gestur Vidarsson	24
17	The Elements Steering Pathogenesis in IgG-Mediated Alloimmune Diseases 2016 ·Journal of Clinical Immunology ·Myrthe E. Sonneveld,C. Ellen van der Schoot,Gestur Vidarsson	6
18	Methylated RASSF1a Is the First Specific DNA Marker for Minimal Residual Disease Testing in Neuroblastoma 2011 ·Clinical Cancer Research ·Janine Stutterheim,(unknown),(unknown),Rogier Versteeg,Huib N. Caron,Godelieve A.M. Tytgat,C. Ellen van der Schoot	28
19	NON-INVASIVE FETAL GENOTYPING OF HUMAN PLATELET ANTIGEN HPA 1A USING CELL-FREE FETAL DNA ISOLATED FROM MATERNAL BLOOD 2010 ·Reproductive Sciences ·P Scheffer,Masja de Haas,Dick Oepkes,Aïcha Ait Soussan,Godelieve C.M.L. Page‐Christiaens,C. Ellen van der Schoot	1
20	Homing of Human Hematopoietic Stem and Progenitor Cells: New Insights, New Challenges? 2001 ·Journal of Hematotherapy & Stem Cell Research ·Carlijn Voermans,Paula B. van Hennik,C. Ellen van der Schoot	38

About C. Ellen van der Schoot

C. Ellen van der Schoot is a scholar working on Hematology, Genetics and Immunology and Allergy, having authored 332 papers that have together received 11.5k indexed citations. Recurring topics across this work include Blood groups and transfusion (141 papers), Platelet Disorders and Treatments (67 papers) and Erythrocyte Function and Pathophysiology (53 papers). The work is most often cited by research in Hematology (5.9k citations), Genetics (2.0k citations) and Immunology and Allergy (756 citations). C. Ellen van der Schoot has collaborated with scholars based in Netherlands, United Kingdom and Germany. Frequent co-authors include Masja de Haas, A. E. G. Kr. von dem Borne, Carlijn Voermans, Gestur Vidarsson, Joke M. Koelewijn, Jacques J. M. van Dongen, Petra A. Maaskant‐van Wijk, Marion Kleijer, Peter C. Ligthart and Vincent H. J. van der Velden. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact